Table 6 Prevalence of primary pathological diagnosis in group II (n = 51)
From: The role of URO17® in diagnosis and follow up of bladder cancer patients
Primary pathology | Number of patients |
|---|---|
PTa | 29 (56.86%) |
pT1 | 18 (35.29%) |
Upper tract urothelial tumors | 4 (7.84%) |